Indeed, the two recent cancer immunology papers have shown that DCs are a crucial source of PD-L1, despite being vastly outnumbered by PD-L1+ macrophages, for the repression of antitumor CD8+ T cell responses in mice (Oh et al., 2020; Peng et al., 2020). The gene discussed is CD8A; the disease is cancer.